Key statistics
On Wednesday, Silo Pharma Inc (SILO:NAQ) closed at 0.291, 7.58% above its 52-week low of 0.2705, set on Feb 05, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.33 |
|---|---|
| High | 0.33 |
| Low | 0.29 |
| Bid | 0.2703 |
| Offer | 0.31 |
| Previous close | 0.2946 |
| Average volume | 123.58k |
|---|---|
| Shares outstanding | 13.32m |
| Free float | 11.44m |
| P/E (TTM) | -- |
| Market cap | 3.88m USD |
| EPS (TTM) | -0.9262 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 21:00 GMT.
More ▼
- Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
- Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD
- Silo Pharma Selects Alphaledger’s T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain
- Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program
- Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company’s Commitment to Multi-Chain Growth
- Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)
- Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management
- Silo Pharma Signs Strategic Agreement with Fireblocks to Advance Crypto Treasury Strategy Acquisition and Security
More ▼
